| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G9012 |
Other specified case management service not elsewhere classified |
12,554 |
10,721 |
$2.50M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,377 |
4,341 |
$1.60M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,630 |
8,881 |
$588K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,564 |
2,391 |
$166K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,279 |
2,242 |
$81K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
520 |
519 |
$40K |
| G9007 |
Coordinated care fee, scheduled team conference |
476 |
474 |
$24K |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
200 |
188 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
134 |
133 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
608 |
528 |
$14K |
| 92551 |
|
992 |
977 |
$13K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
58 |
58 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
96 |
96 |
$8K |
| 86328 |
|
123 |
118 |
$6K |
| 99173 |
|
975 |
958 |
$5K |
| G9920 |
Screening performed and negative |
98 |
97 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
220 |
215 |
$3K |
| 87428 |
|
40 |
40 |
$3K |
| 81003 |
|
1,552 |
1,504 |
$2K |
| 99385 |
|
17 |
17 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64 |
63 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$2K |
| 96127 |
|
274 |
272 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
160 |
143 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
148 |
122 |
$911.01 |
| 71046 |
Radiologic examination, chest; 2 views |
28 |
27 |
$894.38 |
| 80053 |
Comprehensive metabolic panel |
83 |
80 |
$762.77 |
| 84443 |
Thyroid stimulating hormone (TSH) |
47 |
44 |
$693.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
116 |
113 |
$648.44 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$592.54 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
86 |
83 |
$580.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
65 |
63 |
$555.10 |
| 93000 |
|
15 |
14 |
$538.20 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
13 |
$287.92 |
| 85018 |
|
94 |
92 |
$156.04 |
| 81025 |
|
17 |
16 |
$47.60 |
| 82948 |
|
14 |
14 |
$32.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.65 |
| 3080F |
|
153 |
135 |
$0.00 |
| 3074F |
|
504 |
448 |
$0.00 |
| 3075F |
|
75 |
72 |
$0.00 |
| 3079F |
|
150 |
147 |
$0.00 |
| 3077F |
|
255 |
232 |
$0.00 |
| 3725F |
|
250 |
248 |
$0.00 |
| 3078F |
|
521 |
465 |
$0.00 |